SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/826FD66C24D8A747C5295254DCB982E4A1E60ED6EAA314F7F937E787B3E8D5F6253695DA2FF197421F9A36C4EDCB261A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/826FD66C24D8A747C5295254DCB982E4A1E60ED6EAA314F7F937E787B3E8D5F6253695DA2FF197421F9A36C4EDCB261A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/826FD66C24D8A747C5295254DCB982E4A1E60ED6EAA314F7F937E787B3E8D5F6253695DA2FF197421F9A36C4EDCB261A
http://www.w3.org/2000/01/rdf-schema#comment
"our findings demonstrate that CYLD mitigates Nonalcoholic steatohepatitis severity and identify the CYLD-TAK1 axis as a promising therapeutic target for management of the disease."
xsd:string
http://purl.uniprot.org/uniprot/#_22452E9183C30AE9681F1E7B709EAF59CE4659754B3BF77710F2BB46DFC2A3B140B2D203B9D7353E869AAD5CC88B650F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/826FD66C24D8A747C5295254DCB982E4A1E60ED6EAA314F7F937E787B3E8D5F6253695DA2FF197421F9A36C4EDCB261A
http://purl.uniprot.org/uniprot/Q3ZAS1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/826FD66C24D8A747C5295254DCB982E4A1E60ED6EAA314F7F937E787B3E8D5F6253695DA2FF197421F9A36C4EDCB261A
http://purl.uniprot.org/uniprot/#_Q3ZAS1-mappedCitation-29291351
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/826FD66C24D8A747C5295254DCB982E4A1E60ED6EAA314F7F937E787B3E8D5F6253695DA2FF197421F9A36C4EDCB261A